glp 1 schizophrenia agonist GLP-1 drugs tied to lower brain inflammation, higher depression risk An analysis on the role – GLP-1 agonist semaglutide reduced diabetes

Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: pooled analysis of the SUSTAIN 1-5 trials

8b) and calcium responses (Fig

However, the remarkably low utilization of GLP-1 RAs among these patients, as shown in this study, underscores an urgent need to heighten awareness and implementation of this therapeutic approach

J Biol Chem 2012;287:6421-30.ArticlePubMedPMC 47

Our twice-weekly dosing protocol uses smaller doses, which many patients find easier to tolerate compared to standard weekly injections

Those numbers add up fast, creating a calorie surplus that works against the medication